Senate Bill Adds Criminal Liability To Global Drug Safety Enforcement
This article was originally published in The Tan Sheet
Executive Summary
A senior drug company officer or director would be required to certify the veracity of product applications and safety submissions to FDA under Sens. Edward Kennedy and Chuck Grassley's bill to improve safety in global drug manufacturing and distribution
You may also be interested in...
Senate Bill Expands FDA's OTC Manufacturing Oversight
Legislation introduced in the Senate to give FDA mandatory recall authority for all drugs would bar the agency from considering a drug's prescription status when assessing risk to prioritize inspections
Globalization Act’s Drug Safety Provisions Look Harmful For Industry
The FDA Globalization Act could be devastating to the drug industry while not creating the safety improvements that Congress expects, according to former FDA attorneys
FDA Ups Foreign Inspections In Fiscal 07; Visits 11% Of Establishments
Data from a Government Accountability Office report suggest FDA took to heart criticism of its procedures for inspecting foreign drug manufacturers, but is struggling to improve performance given financial pressures